181 related articles for article (PubMed ID: 3131115)
1. Differential responses of sex steroid target tissues of rats treated with 4-hydroxyandrostenedione.
Wing LY; Hammond JO; Brodie AM
Endocrinology; 1988 Jun; 122(6):2418-27. PubMed ID: 3131115
[TBL] [Abstract][Full Text] [Related]
2. Effects of aromatase inhibitors, aminoglutethimide, and 4-hydroxyandrostenedione on cyclic rats and rats with 7,12-dimethylbenz(a)anthracene-induced mammary tumors.
Wing LY; Garrett WM; Brodie AM
Cancer Res; 1985 Jun; 45(6):2425-8. PubMed ID: 3921242
[TBL] [Abstract][Full Text] [Related]
3. The effect of aromatase inhibitor 4-hydroxyandrostenedione on steroid receptors in hormone-dependent tissues of the rat.
Zhou JL; Brodie A
J Steroid Biochem Mol Biol; 1995 Jan; 52(1):71-6. PubMed ID: 7857875
[TBL] [Abstract][Full Text] [Related]
4. Effect of aromatase inhibitors on growth of mammary tumors in a nude mouse model.
Yue W; Wang J; Savinov A; Brodie A
Cancer Res; 1995 Jul; 55(14):3073-7. PubMed ID: 7606729
[TBL] [Abstract][Full Text] [Related]
5. Aromatase inhibitors prevent granulosa cell differentiation: an obligatory role for estrogens in luteinizing hormone receptor expression.
Knecht M; Brodie AM; Catt KJ
Endocrinology; 1985 Sep; 117(3):1156-61. PubMed ID: 2990868
[TBL] [Abstract][Full Text] [Related]
6. Effects of aromatase inhibitor 4-hydroxyandrostenedione and other compounds in the 7, 12-dimethylbenz(a)anthracene-induced breast carcinoma model.
Brodie AM; Garrett WM; Hendrickson JR; Tsai-Morris CH
Cancer Res; 1982 Aug; 42(8 Suppl):3360s-3364s. PubMed ID: 6805949
[TBL] [Abstract][Full Text] [Related]
7. Androgen-uterine interactions: an assessment of androgen interaction with the testosterone- and estrogen-receptor systems and stimulation of uterine growth and progesterone-receptor synthesis.
Schmidt WN; Katzenellenbogen BS
Mol Cell Endocrinol; 1979 Aug; 15(2):91-108. PubMed ID: 499651
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo studies with aromatase inhibitor 4-hydroxy-androstenedione.
Brodie AM; Wing LY
Steroids; 1987; 50(1-3):89-103. PubMed ID: 3504069
[TBL] [Abstract][Full Text] [Related]
9. Dietary genistein results in larger MNU-induced, estrogen-dependent mammary tumors following ovariectomy of Sprague-Dawley rats.
Allred CD; Allred KF; Ju YH; Clausen LM; Doerge DR; Schantz SL; Korol DL; Wallig MA; Helferich WG
Carcinogenesis; 2004 Feb; 25(2):211-8. PubMed ID: 14578162
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the actions of the antiprogestin mifepristone (RU486), the progestin megestrol acetate, the LHRH analog buserelin, and ovariectomy in treatment of rat mammary tumors.
Bakker GH; Setyono-Han B; Henkelman MS; de Jong FH; Lamberts SW; van der Schoot P; Klijn JG
Cancer Treat Rep; 1987 Nov; 71(11):1021-7. PubMed ID: 3119199
[TBL] [Abstract][Full Text] [Related]
11. Androgen control of cytosol progesterone receptor levels in the MT-W9B transplantable mammary tumor in the rat.
Ip MM; Milholland RJ; Kim U; Rosen F
J Natl Cancer Inst; 1982 Sep; 69(3):673-81. PubMed ID: 6955558
[TBL] [Abstract][Full Text] [Related]
12. Effect of treatment with aromatase inhibitor 4-hydroxandrostenedione on the nonhuman primate menstrual cycle.
Brodie AM; Hammond JO; Ghosh M; Meyer K; Albrecht ED
Cancer Res; 1989 Sep; 49(17):4780-4. PubMed ID: 2758411
[TBL] [Abstract][Full Text] [Related]
13. Similarities and differences in progesterone and androgens in modulation of LH, FSH and PRL release: unexpected properties of flutamide.
Brann DW; Putnam CD; Mahesh VB
J Steroid Biochem; 1990 Jul; 36(4):287-94. PubMed ID: 2118203
[TBL] [Abstract][Full Text] [Related]
14. Regulation of progesterone receptor gene expression and growth in the rat uterus: modulation of estrogen actions by progesterone and sex steroid hormone antagonists.
Kraus WL; Katzenellenbogen BS
Endocrinology; 1993 Jun; 132(6):2371-9. PubMed ID: 8504742
[TBL] [Abstract][Full Text] [Related]
15. Sensitivity of a Tier I screening battery compared to an in utero exposure for detecting the estrogen receptor agonist 17 beta-estradiol.
O'Connor JC; Frame SR; Biegel LB; Cook JC; Davis LG
Toxicol Sci; 1998 Aug; 44(2):169-84. PubMed ID: 9742655
[TBL] [Abstract][Full Text] [Related]
16. Aromatase inhibitors and their potential clinical significance.
Brodie AM; Wing LY; Goss P; Dowsett M; Coombes RC
J Steroid Biochem; 1986 Nov; 25(5B):859-65. PubMed ID: 3807367
[TBL] [Abstract][Full Text] [Related]
17. Aromatase inhibitors: basic and clinical studies.
Brodie AM; Coombes RC; Dowsett M
J Steroid Biochem; 1987; 27(4-6):899-903. PubMed ID: 3320568
[TBL] [Abstract][Full Text] [Related]
18. Effects of nafoxidine on the luteinizing hormone surge: temporal distribution of estrogen receptors and induction of cytoplasmic progestin receptors in the hypothalamus-preoptic area, pituitary, and uterus of the immature rat.
Attardi B; Palumbo LA
Endocrinology; 1981 Nov; 109(5):1365-74. PubMed ID: 7297482
[TBL] [Abstract][Full Text] [Related]
19. Effects of the aromatase inhibitor 4-hydroxyandrostenedione and the antiandrogen flutamide on growth and steroid levels in DMBA-induced rat mammary tumors.
Spinola PG; Marchetti B; Mérand Y; Bélanger A; Labrie F
Breast Cancer Res Treat; 1988 Dec; 12(3):287-96. PubMed ID: 3147727
[TBL] [Abstract][Full Text] [Related]
20. Modulation of rat uterine steroid hormone receptors by estrogen and antiestrogen.
Dix CJ; Jordan VC
Endocrinology; 1980 Dec; 107(6):2011-20. PubMed ID: 7191796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
